Conditions: Erythema Rosacea
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 440
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of AGN-199201 once daily compared to vehicle for the treatment of persistent moderate to severe facial erythema associated with rosacea.

Detailed description:

Arms:
arm 1: AGN-199201 applied to the face once daily for 29 days. arm 2: Vehicle to AGN-199201 applied to the face once daily for 29 days.

Interventions: intervention 1: AGN-199201 intervention 2: Vehicle to AGN-199201
Intervention descriptions: intervention 1: AGN-199201 applied to the face once daily for 29 days. intervention 2: Vehicle to AGN-199201 applied to the face once daily for 29 days.

Protocol document: